The changing face of tuberculosis in drug discovery
Stewart Cole FRS is a Professor of Microbial Pathogenesis and President of the Institut Pasteur in Paris, France. Following his previous roles as acting President, Senior Vice President and Scientific Director at the Institut Pasteur, he became President of the institution in January 2018.
Cole obtained his PhD in molecular genetics from the University of Sheffield and subsequently embarked on a career as a research scientist at the University of Umeå (Sweden) and the Max-Planck-Institut in Tübingen (Germany). He has published over 350 scientific papers and review articles, most notably on tuberculosis and leprosy, and contributed to several patent applications relating to HIV/AIDS, cervical cancer and multidrug-resistant tuberculosis.
Cole is a former Full Professor at the Ecole Polytechnique Fédérale de Lausanne (EPFL), where he was Director of the Global Health Institute. He is Fellow of the Royal Society in London, Chevalier de la Légion d’Honneur in France, an EMBO member and a recipient of many other honours including the Kochon Prize.